Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Allergy & Immunology
•
Drug Allergy
•
Hospital Medicine
•
General Hospital Medicine
When do you attempt penicillin de-labeling in hospitalized patients?
What method(s) do you use?
Related Questions
What is your approach to distinguishing a Jarisch-Herxheimer reaction from a delayed anaphylactoid reaction?
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
How do you weigh the risk of urinary catheter or fecal management system placement with that of soiling sacral wounds?
Do you consider holding PPIs in patients hospitalized with infections like pneumonia or C. diff colitis?
How do you consider sending fungal studies in a patient with pneumonia?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
Do you use MRSA nares PCR to influence antibiotic selection for non-respiratory infections?
For patients initially presenting with fever who are not improving clinically but cultures and imaging are all negative after 48-72 hours, how do you weigh other biomarkers such as WBCs, procalcitonin, CRP, etc. when deciding to discontinue antibiotics?
What is your approach to a situation where DILI is suspected secondary to an important medication (e.g., anticoagulation, antibiotics, etc.), but the diagnosis is uncertain and the liver injury is relatively mild?
Do you routinely discontinue atypical coverage in community-acquired pneumonia when PCR testing (i.e., respiratory pathogen panel) is negative for atypical organisms?